Magenta Therapeutics, Inc.MGTANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank25
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P25
Within normal range
vs 3Y Ago
-9.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-65.08%
20240.00%
2022-12.70%
20217.02%
2020-12.12%
2019-36.33%
2018-88.14%
2017-240.99%
20160.00%